...Neon Therapeutics Inc. (NASDAQ:NTGN), Cambridge, Mass. Novartis AG (NYSE:NVS), Basel, Switzerland ToolGen Inc. (KONEX:199800), Seoul, Korea University...
...Md. email: wutc@jhmi.edu CONTACT: Tae Woo Kim, Korea University, Seoul, South Korea email: twkim0421@korea.com
Sandi Wong
Johns Hopkins University
Korea University
ATP...
...oxygen species modulator 1 (ROMO1) Colorectal cancer Cell-based Inhibiting ROMO1 could help treat colorectal cancer. Korea University... ...the cancer cells into non-tumorigenic cells ( No. 1341 ). In addition, a group from Korea University... ...Leverkusen, Germany Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Expansion Therapeutics Inc., San Diego, Calif. Korea University...
...online July 17, 2017 doi:10.1158/0008-5472.CAN-17-0072 CONTACT: Tae Woo Kim, Korea University, Seoul, South Korea email: twkim0421@korea.ac.kr
Hongjiang Li
Korea University
Granzyme...
...Neon Therapeutics Inc. (NASDAQ:NTGN), Cambridge, Mass. Novartis AG (NYSE:NVS), Basel, Switzerland ToolGen Inc. (KONEX:199800), Seoul, Korea University...
...Md. email: wutc@jhmi.edu CONTACT: Tae Woo Kim, Korea University, Seoul, South Korea email: twkim0421@korea.com
Sandi Wong
Johns Hopkins University
Korea University
ATP...
...oxygen species modulator 1 (ROMO1) Colorectal cancer Cell-based Inhibiting ROMO1 could help treat colorectal cancer. Korea University... ...the cancer cells into non-tumorigenic cells ( No. 1341 ). In addition, a group from Korea University... ...Leverkusen, Germany Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Expansion Therapeutics Inc., San Diego, Calif. Korea University...
...online July 17, 2017 doi:10.1158/0008-5472.CAN-17-0072 CONTACT: Tae Woo Kim, Korea University, Seoul, South Korea email: twkim0421@korea.ac.kr
Hongjiang Li
Korea University
Granzyme...